Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 4  + (Annex XIV Chapter II Section 4)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 1.12  + (Annex XIV Chapter II Section 1.12)
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Annex XIV Chapter II Section 2  + (Annex XIV Chapter II Section 2)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter I Section 2  + (Annex XV Chapter I Section 2)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter II Section 1.7  + (Annex XV Chapter II Section 1.7)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 1. ; 3.  + (Annex XV Chapter III 1. ; 3.)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III 2. ; 7.  + (Annex XV Chapter III 2. ; 7.)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III Paragraph 3  + (Annex XV Chapter III Paragraph 3)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Annex XV Chapter III Section 4  + (Annex XV Chapter III Section 4)
• Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 Appendix 1  + (Appendix 1)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Appendix 2  + (Appendix 2)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix A  + (Appendix A)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix A 3.4  + (Appendix A 3.4)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B  + (Appendix B)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 12.3  + (Appendix B 12.3)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 14.3  + (Appendix B 14.3)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 16  + (Appendix B 16)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 2.5  + (Appendix B 2.5)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 4.8-001  + (Appendix B 4.8)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 4.8-002  + (Appendix B 4.8)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 5  + (Appendix B 5)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 6-001  + (Appendix B 6)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 6-002  + (Appendix B 6)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 8  + (Appendix B 8)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B 9.4  + (Appendix B 9.4)

• Reference:ICH ICH E6 Guideline R3 (2025) Appendix B. B4  + (Appendix B. B4)

• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C-001  + (Appendix C)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C-002  + (Appendix C)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C 2  + (Appendix C 2)
• Reference:ICH ICH E6 Guideline R3 (2025) Appendix C C.2.3  + (Appendix C C.2.3)
• Reference:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 Appendix I  + (Appendix I)
• Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix I  + (Appendix I)
• Reference:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 Appendix II  + (Appendix II)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 10  + (Article 10)
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (b)-001  + (Article 10 (b))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (b)-002  + (Article 10 (b))
• Reference:GBR Directive 2001/20/EC 04-Apr-2001 Article 10 (c)  + (Article 10 (c))
• Reference:EU Directive 2001/83/EC - Community code relating to medicinal products for human use 20-Jun-12 Article 107m (1)  + (Article 107m (1))
• Reference:EU Directive 2001/83/EC - Community code relating to medicinal products for human use 20-Jun-12 Article 107n  + (Article 107n)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 109 Paragraph 1-001  + (Article 109 Paragraph 1)
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 109 Paragraph 1-002  + (Article 109 Paragraph 1)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 11  + (Article 11)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11  + (Article 11)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11 - 12  + (Article 11 - 12)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 12  + (Article 12)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 13  + (Article 13)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 14  + (Article 14)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 14  + (Article 14)
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 15  + (Article 15)
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (1) - (6)  + (Article 15 (1) - (6))
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 15 (5) (d)  + (Article 15 (5) (d))